Core Insights - Ripple is supporting a new publicly traded XRP treasury firm named Evernorth, which aims to raise over $1 billion and has enlisted key Ripple backers for its initiative [1][2] - The deal is expected to close in Q1 2026, with net proceeds exceeding $1 billion primarily intended for purchasing XRP on the open market [2] - Evernorth's strategy includes generating returns for shareholders while enhancing XRP's utility and adoption, maintaining independent governance but receiving strategic advisory from Ripple executives [3][4] Company Strategy - Evernorth aims to capitalize on traditional finance yield generation strategies and explore decentralized finance (DeFi) yield opportunities, contributing to the growth of the XRP ecosystem [3] - The firm plans to engage in validator operations, DeFi, and market development by providing liquidity and participating in projects that advance XRP [5] - Evernorth's $1 billion XRP treasury would position it as the largest publicly traded XRP reserve, with other firms also planning significant XRP acquisitions [6]

Market Overview - The price of XRP has increased approximately 7% as of 10:45 a.m. ET today, reflecting a general rebound in the cryptocurrency market over the weekend [1] - The broader cryptocurrency market faced challenges last week due to escalating trade tensions between the U.S. and China, alongside concerns over bad bank loans [2] - Recent developments indicate a more positive sentiment among investors regarding the bad bank loans, which are perceived as idiosyncratic rather than indicative of a broader economic downturn [3] XRP-Specific Developments - A crypto start-up backed by Ripple, the company behind XRP, announced plans to go public through a merger with a blank-check company, potentially raising up to $1 billion [4] - Evernorth's strategy includes a crypto-treasury approach that involves purchasing large amounts of XRP and seeking acquisition opportunities [4] - XRP's position as the third-largest cryptocurrency by market cap, excluding stablecoins, positions it favorably for attention from crypto-treasury companies [5] Investment Potential - XRP has significant potential to disrupt international payments, particularly due to its association with Ripple, suggesting that investors may consider taking a speculative position [6]

David never really left Ripple.David is still here but in a different capacity and it’s as a Strategic Advisor for @evernorthxrpDefi and $XRPDavid 'JoelKatz' Schwartz (@JoelKatz):XRP community – I promised I’d have an update on my next adventure soon right? Well here’s the start: I’ll be a strategic advisor to @evernorthxrp, helmed by my friend @ashgoblue.Evernorth was founded as a regulated, scalable investment vehicle to tap into opportunities for ...

Funding & Investment - Evernorth SPAC, backed by Ripple veterans and crypto heavyweights, aims to raise $1 billion [1] - The goal is to build the largest public XRP treasury [1]

🚨 NEW: Ripple-backed Evernorth plans a US listing, aiming to raise over $1B and build the largest public $XRP treasury. https://t.co/kT68yJN98k ...

🚨UPDATE: EVERNORTH ENTERS AGREEMENT TO RAISE OVER $1 BILLION THROUGH A PUBLIC $XRP TREASURY COMPANY ON NASDAQ UNDER "XRPN" ...

Evernorth, backed by Ripple, plans a Nasdaq listing to raise over $1 billion for building the largest publicly traded XRP treasury. The deal is expected to close in early 2026 with key investors including SBI, Pantera Capital, and Kraken. https://t.co/QNVkfvWWoV ...

Group 1 - Evernorth, a new crypto venture backed by Ripple, plans to list on Nasdaq through a merger with Armada Acquisition Corp II, aiming to raise over $1 billion [1][2] - The digital asset treasury will focus on accumulating XRP, the fifth-largest cryptocurrency by market cap [1] - The deal is expected to close in the first quarter of 2026, creating the largest publicly traded XRP treasury company [2] Group 2 - The merger follows the resolution of a high-profile lawsuit against Ripple regarding the sale of unregistered securities [2] - Evernorth's CEO, Asheesh Birla, will step down from Ripple's board to join Evernorth, which will also seek acquisition opportunities and build an investment team [4][5] - Japanese firm SBI is contributing $200 million to the raise in exchange for equity [4]

Core Insights - Evernorth, the health services division of The Cigna Group, has launched a new pharmacy benefit offering that makes weight loss medications WEGOVY® and ZEPBOUND® more accessible to patients, with a maximum monthly cost of $200 [1][6]. Patient Benefits - Patients can save up to $3,600 annually compared to direct-to-consumer manufacturer programs [6][7]. - Monthly copays for GLP-1 weight loss medications will be capped at $200, which will count towards the patient's annual deductible [7]. - The new offering ensures access to FDA-approved medications with robust safety checks to minimize adverse drug interactions [7]. - The prior authorization process will be simplified and automated for quicker access to medications [7]. - Patients have the option to choose from a wide network of local retail pharmacies or home delivery through Evernorth's EnGuide Pharmacy [7]. Employer and Health Plan Sponsor Benefits - Health plan sponsors will experience a significant reduction in the net cost per prescription for GLP-1 medications [7]. - The initiative addresses the growing demand for FDA-approved weight loss medications while ensuring clinical safety for patients [6][7]. - Evernorth's extensive suite of GLP-1 solutions provides health plan sponsors with options to ensure patients have access to the most suitable medications without compromising affordability [7]. Additional Information - EncircleRx has saved health plans $200 million since 2024, with over 9 million enrolled lives [8]. - EnReachRx is a patient support clinical model designed for dispensing GLP-1 prescription medications [8].